<DOC>
	<DOCNO>NCT00407030</DOCNO>
	<brief_summary>At baseline patient receive incobotulinumtoxinA ( Xeomin ) placebo . Thereafter , patient enter extension period treat five injection session incobotulinumtoxinA ( Xeomin ) extension period .</brief_summary>
	<brief_title>IncobotulinumtoxinA ( Xeomin ) Versus Placebo Treatment Cervical Dystonia</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Main Male female outpatient age 18 75 year inclusive ) A clinical diagnosis cervical dystonia ( i.e . spasmodic torticollis ) predominantly rotational form need injection ( determine Toronto Western Spasmodic Torticollis Rating Scale ( TWSTRS ) Total score ) TWSTRSTotal score &gt; = 20 TWSTRSSeverity score &gt; = 10 TWSTRSDisability score &gt; = 3 TWSTRSPain score &gt; = 1 On stable dose medication ( ) use focal dystonia treatment ( e.g . anticholinergic benzodiazepine ) least 3 month prior expect throughout Main Period For pretreated patient : Source documentation last two consecutive injection session Botulinum Toxin stable therapeutic response directly prior trial entry For pretreated patient : At least 10 week must pass last injection Botulinum Toxin cervical dystonia baseline For pretreated patient : The recent injection Botulinum Toxin must maximal 300 Units type A 12,000 Units type B Main Traumatic torticollis tardive torticollis TWSTRSSeverity score anterocollis &gt; = 2 point ( pure anterocollis ) TWSTRSSeverity score retrocollis &gt; = 2 point ( pure retrocollis ) Myotomy denervation surgery affect muscle ( e.g . peripheral denervation and/or spinal cord stimulation ) Hypersensitivity human serum albumin , sucrose , Botulinum Toxin Type A Diagnosis myasthenia gravis , LambertEaton syndrome , amyotrophic lateral sclerosis , significant neuromuscular disease might interfere trial Current swallow disorder origin ( dysphagia scale &gt; = 3 , i.e . severe , swallow difficulty require change diet ) Marked limitation passive range motion suggest contractures structural abnormality , e.g . cervical contracture cervical spine syndrome Treatment Botulinum Toxins indication cervical dystonia within 4 month prior baseline trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>